跳至主要内容
临床试验/NCT07445451
NCT07445451已完成不适用

A Randomized Controlled Trial of the Analgesic, Hemodynamic, and Respiratory Effects of Intravenous Magnesium Sulfate and Dexmedetomidine Infusions During Transurethral Bladder Tumor Resection Under Spinal Anesthesia

Dr. Lutfi Kirdar Kartal Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2024年12月15日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
93
试验地点
1
主要终点
Total Postoperative Analgesic Consumption

研究概览

简要总结

This randomized controlled trial evaluated the effects of intraoperative intravenous magnesium sulfate versus dexmedetomidine on postoperative pain, analgesic consumption, hemodynamic stability, and respiratory function in patients undergoing elective transurethral resection of bladder tumor (TUR-M) under spinal anesthesia. Magnesium sulfate significantly reduced postoperative pain scores, delayed the time to first analgesic request, and decreased total analgesic consumption compared to dexmedetomidine and control groups, while both agents were hemodynamically and respiratorily safe.

详细描述

This study is a prospective, randomized, controlled trial designed to evaluate the effects of intraoperative intravenous magnesium sulfate versus dexmedetomidine infusions in patients undergoing elective transurethral resection of bladder tumor (TUR-M) under spinal anesthesia. Adult patients (age 18-85 years) with ASA physical status I-III scheduled for TUR-M were enrolled. Participants were randomly assigned to receive either magnesium sulfate, dexmedetomidine, or saline infusion during surgery. All patients received standardized spinal anesthesia. The study assesses postoperative pain, analgesic consumption, hemodynamic and respiratory parameters, and side effects. The trial aims to determine which agent provides better postoperative analgesia while maintaining cardiovascular and respiratory safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 and 85 years. Classified as ASA physical status I, II, or III according to the American Society of Anesthesiologists.
  • Patients scheduled for elective transurethral resection of bladder tumor (TUR-M) under spinal anesthesia.

排除标准

  • Patients under 18 years or over 85 years of age. Contraindications to spinal anesthesia (e.g., infection at puncture site, coagulopathy).
  • History or current diagnosis of significant cardiac arrhythmia. Known allergy or contraindication to the study drugs (magnesium sulfate or dexmedetomidine).
  • Patients requiring conversion to general anesthesia due to inadequate spinal anesthesia intraoperatively.
  • Mental retardation, cognitive impairment, or communication difficulties that prevent understanding of study procedures or pain assessment.
  • Patients who refuse to participate in the study.

研究组 & 干预措施

Magnesium Sulfate Infusion Group

Experimental

Patients receive intravenous magnesium sulfate at 15 mg/kg/hour during TUR-M surgery under spinal anesthesia. Infusion solution is prepared aseptically by diluting the calculated dose in 50 mL of 0.9% NaCl. Postoperative analgesia is administered as rescue treatment based on VAS scores.

干预措施: magnesium sulfate (Drug)

Dexmedetomidine Infusion Group

Experimental

Patients receive intravenous dexmedetomidine at 0.5 µg/kg/hour during TUR-M surgery under spinal anesthesia. The calculated dose is diluted in 50 mL of 0.9% NaCl and infused intravenously. Postoperative analgesia is given as rescue treatment according to VAS scores.

干预措施: Dexmedetomidine (Drug)

Control Group (Saline Infusion)

Active Comparator

Patients receive intravenous normal saline at 15 mL/kg/hour during TUR-M surgery under spinal anesthesia. Infusion is administered with the same protocol and devices as the experimental arms to maintain blinding. Postoperative analgesia is provided as rescue treatment based on VAS scores.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Total Postoperative Analgesic Consumption

时间窗: 24 hours postoperative

Total amount of analgesics (paracetamol and tramadol) administered within 24 hours after surgery.

Time to First Analgesic Request

时间窗: Postoperative period up to 24 hours

Time (in minutes) from the end of surgery until the patient first requests postoperative analgesia.

Postoperative Pain Scores

时间窗: 24 hours postoperative

Pain intensity measured using the Visual Analog Scale (VAS) at the end of surgery, 60 minutes, 6 hours, and 24 hours after surgery.

次要结局

  • Integrated Pulmonary Index (IPI)(During surgery)
  • Intraoperative heart rate(During surgery)
  • Intraoperative systolic blood pressure(During surgery)
  • Intraoperative diastolic blood pressure(During surgery)
  • Intraoperative mean arterial pressure(During surgery)
  • Adverse Effects(Intraoperative and 24 hours postoperative)

研究者

发起方
Dr. Lutfi Kirdar Kartal Training and Research Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Halil Ibrahım Yuksel

Resident Physician, Department of Anesthesiology and Reanimation

Dr. Lutfi Kirdar Kartal Training and Research Hospital

研究点 (1)

Loading locations...

相似试验

Magnesium vs. Dexmedetomidine in TURBT Under Spinal... | 临床试验